Labs running multi-assay protocols need compound consistency from the first experiment to the last
M., Marcus, C., et al
Practical Meal Planning Tips for People Taking Retatrutide Eating four to five small, nutrient-dense meals spread throughout the day, preparing food in advance, and stopping at the first sign of fullness are the most effective strategies for managing reduced appetite on retatrutide
Tirzepatide addresses multiple cardiovascular risk factors, including weight, insulin resistance, inflammation, and dyslipidemia, potentially providing a net cardiovascular benefit rather than introducing new risk
Victoza (liraglutide), the first GLP-1 for type 2 diabetes to lose exclusivity in June 2024, may not generate significant savings due to its once-daily dosing and limited market share
Zepbound was FDA-approved in 2023 for long-term weight management in adults with obesity (with a body mass index of 30 or higher) and overweight (with a body mass index of 27 or higher) with at least one weight-related condition, such as high blood pressure, type 2 diabetes, or high cholesterol
